Last 12 months
Inside the activity.
0 purchase rows · 74 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 5 |
| Dec 2025 | 0 | 3 |
| Jan 2026 | 0 | 13 |
| Feb 2026 | 0 | 3 |
| Mar 2026 | 0 | 5 |
| Apr 2026 | 0 | 3 |
| May 2026 | 0 | 3 |
| Jun 2026 | 0 | 15 |
| Jul 2026 | 0 | 12 |
| Aug 2026 | 0 | 5 |
| Sep 2026 | 0 | 6 |
| Oct 2026 | 0 | 1 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 12, 2026 Filed Feb 18, 2026 00:53 UTC |
Patel AnishCHIEF OPERATING OFFICER
|
GrantCommon Stock | 20,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001967163-26-000002 · form4-02182026_120233.xml · nonDerivative · entry 1 Patel Anish · CIK 0001967163 · CHIEF OPERATING OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,000 F1 · shares: These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. 1/4th of the RSUs will vest on March 1, 2027 and 1/16th of the RSUs will vest each June 1, September 1, December 1, and March 1 thereafter, subject to the Reporting Person continuing as a service provider through each such date. F1 · balance_after: These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. 1/4th of the RSUs will vest on March 1, 2027 and 1/16th of the RSUs will vest each June 1, September 1, December 1, and March 1 thereafter, subject to the Reporting Person continuing as a service provider through each such date. Read SEC document |
| February 12, 2026 Filed Feb 18, 2026 00:56 UTC |
Bauer JakeDirector
|
GrantStock Option (right to buy) · Derivative | 17,126 | $0.00 Strike: $27.16 | $0.00 |
DisclosureSEC source: 0001654909-26-000001 · form4-02182026_120203.xml · derivative · entry 1 Bauer Jake · CIK 0001654909 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,126 Underlying: Common Stock · 17,126 shares Expires 2036-02-12 F1 · derivative.exercise_date: 100% of the shares subject to the option will vest on the earlier of (i) the first anniversary of the 2026 annual meeting of the Issuer's stockholders or (ii) the date of the 2027 annual meeting of the Issuer's stockholders, subject to the Reporting Person continuing as a non-employee director through the applicable vesting date. Read SEC document |
| February 12, 2026 Filed Feb 18, 2026 00:49 UTC |
Hohl BenjaminCHIEF FINANCIAL OFFICER
|
GrantStock Option (right to buy) · Derivative | 150,000 | $0.00 Strike: $27.16 | $0.00 |
DisclosureSEC source: 0001882764-26-000001 · form4-02182026_120228.xml · derivative · entry 2 Hohl Benjamin · CIK 0001882764 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 150,000 Underlying: Common Stock · 150,000 shares Expires 2036-02-12 F3 · derivative.exercise_date: 1/4th of the shares subject to the option will vest on February 12, 2027 and 1/48th of the shares subject to the option will vest each month thereafter, subject to the Reporting Person continuing as a service provider through each such date. Read SEC document |
| February 12, 2026 Filed Feb 18, 2026 00:49 UTC |
Hohl BenjaminCHIEF FINANCIAL OFFICER
|
GrantCommon Stock | 25,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001882764-26-000001 · form4-02182026_120228.xml · nonDerivative · entry 1 Hohl Benjamin · CIK 0001882764 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 61,000 F1 · shares: These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. 1/4th of the RSUs will vest on March 1, 2027 and 1/16th of the RSUs will vest each June 1, September 1, December 1, and March 1 thereafter, subject to the Reporting Person continuing as a service provider through each such date. F2 · balance_after: Certain of these securities are RSUs. Each RSU represents a contingent right to receive one share of the Issuer's Common Stock, subject to the applicable vesting schedule and conditions of each RSU. Read SEC document |
| February 12, 2026 Filed Feb 18, 2026 00:47 UTC |
Collins Helen LouiseCHIEF MEDICAL OFFICER
|
GrantStock Option (right to buy) · Derivative | 150,000 | $0.00 Strike: $27.16 | $0.00 |
DisclosureSEC source: 0001701247-26-000001 · form4-02182026_120250.xml · derivative · entry 2 Collins Helen Louise · CIK 0001701247 · CHIEF MEDICAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 150,000 Underlying: Common Stock · 150,000 shares Expires 2036-02-12 F2 · derivative.exercise_date: 1/4th of the shares subject to the option will vest on February 12, 2027 and 1/48th of the shares subject to the option will vest each month thereafter, subject to the Reporting Person continuing as a service provider through each such date. Read SEC document |
| February 12, 2026 Filed Feb 18, 2026 00:47 UTC |
Collins Helen LouiseCHIEF MEDICAL OFFICER
|
GrantCommon Stock | 25,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001701247-26-000001 · form4-02182026_120250.xml · nonDerivative · entry 1 Collins Helen Louise · CIK 0001701247 · CHIEF MEDICAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,000 F1 · shares: These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. 1/4th of the RSUs will vest on March 1, 2027 and 1/16th of the RSUs will vest each June 1, September 1, December 1, and March 1 thereafter, subject to the Reporting Person continuing as a service provider through each such date. F1 · balance_after: These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. 1/4th of the RSUs will vest on March 1, 2027 and 1/16th of the RSUs will vest each June 1, September 1, December 1, and March 1 thereafter, subject to the Reporting Person continuing as a service provider through each such date. Read SEC document |
| February 06, 2026 Filed Feb 10, 2026 18:12 UTC |
Lyssikatos Joseph PCHIEF SCIENTIFIC OFFICER
|
SaleCommon Stock | 5,000 | $29.04 | $145,219.00 |
DisclosureSEC source: 0001967150-26-000003 · form4-02102026_110257.xml · nonDerivative · entry 1 Lyssikatos Joseph P · CIK 0001967150 · CHIEF SCIENTIFIC OFFICER 10b5-1 filing: Plan reported Ownership: Indirect · See footnote Disclosed balance after: 740,188 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 15, 2024. F2 · price: This transaction was executed in multiple trades at prices ranging from $28.925 to $29.14. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. F3 · ownership.nature: The shares are held by The Lyssikatos Revocable Trust 12/15/2011 for which the Reporting Person serves as trustee. Read SEC document |
| January 20, 2026 Filed Jan 22, 2026 17:34 UTC |
Lyssikatos Joseph PCHIEF SCIENTIFIC OFFICER
|
SaleCommon Stock | 14,509 | $26.90 | $390,284.85 |
DisclosureSEC source: 0001967150-26-000002 · form4-01222026_100144.xml · nonDerivative · entry 2 Lyssikatos Joseph P · CIK 0001967150 · CHIEF SCIENTIFIC OFFICER 10b5-1 filing: Plan reported Ownership: Indirect · See footnote Disclosed balance after: 745,188 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 15, 2024. F4 · price: This transaction was executed in multiple trades at prices ranging from $26.6137 to $27.344. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. F3 · ownership.nature: The shares are held by The Lyssikatos Revocable Trust 12/15/2011 for which the Reporting Person serves as trustee. Read SEC document |
| January 20, 2026 Filed Jan 22, 2026 17:34 UTC |
Lyssikatos Joseph PCHIEF SCIENTIFIC OFFICER
|
SaleCommon Stock | 5,491 | $26.37 | $144,814.14 |
DisclosureSEC source: 0001967150-26-000002 · form4-01222026_100144.xml · nonDerivative · entry 1 Lyssikatos Joseph P · CIK 0001967150 · CHIEF SCIENTIFIC OFFICER 10b5-1 filing: Plan reported Ownership: Indirect · See footnote Disclosed balance after: 759,697 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 15, 2024. F2 · price: This transaction was executed in multiple trades at prices ranging from $25.605 to $26.5928. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. F3 · ownership.nature: The shares are held by The Lyssikatos Revocable Trust 12/15/2011 for which the Reporting Person serves as trustee. Read SEC document |
| January 20, 2026 Filed Jan 22, 2026 22:33 UTC |
Heyman Richard A.Director
|
SaleCommon Stock | 718 | $26.96 | $19,354.41 |
DisclosureSEC source: 0001584759-26-000007 · form4-01222026_100111.xml · nonDerivative · entry 2 Heyman Richard A. · CIK 0001584759 · Director 10b5-1 filing: Plan reported Ownership: Indirect · See footnote Disclosed balance after: 23,877 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 15, 2024 by the Reporting Person and by Richard A. Heyman and Anne E. Daigle Trust, UAD 01/01/1995, as amended November 1, 2016, for which the Reporting Person serves as trustee (the "Heyman Daigle Trust"). F4 · price: This transaction was executed in multiple trades at prices ranging from $26.725 to $27.3454. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. F3 · ownership.nature: The shares are held of record by the Heyman Daigle Trust. Read SEC document |
| January 20, 2026 Filed Jan 22, 2026 22:33 UTC |
Heyman Richard A.Director
|
SaleCommon Stock | 512 | $26.46 | $13,547.11 |
DisclosureSEC source: 0001584759-26-000007 · form4-01222026_100111.xml · nonDerivative · entry 1 Heyman Richard A. · CIK 0001584759 · Director 10b5-1 filing: Plan reported Ownership: Indirect · See footnote Disclosed balance after: 24,595 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 15, 2024 by the Reporting Person and by Richard A. Heyman and Anne E. Daigle Trust, UAD 01/01/1995, as amended November 1, 2016, for which the Reporting Person serves as trustee (the "Heyman Daigle Trust"). F2 · price: This transaction was executed in multiple trades at prices ranging from $25.7133 to $26.7111. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. F3 · ownership.nature: The shares are held of record by the Heyman Daigle Trust. Read SEC document |
| January 09, 2026 Filed Jan 12, 2026 17:12 UTC |
Lyssikatos Joseph PCHIEF SCIENTIFIC OFFICER
|
SaleCommon Stock | 50,000 | $29.13 | $1,456,715.00 |
DisclosureSEC source: 0001967150-26-000001 · form4-01122026_100153.xml · nonDerivative · entry 4 Lyssikatos Joseph P · CIK 0001967150 · CHIEF SCIENTIFIC OFFICER 10b5-1 filing: Plan reported Ownership: Indirect · See footnote Disclosed balance after: 765,188 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 15, 2024. F6 · price: This transaction was executed in multiple trades at prices ranging from $28.90 to $29.14. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. F3 · ownership.nature: The shares are held by The Lyssikatos Revocable Trust 12/15/2011 for which the Reporting Person serves as trustee. Read SEC document |
| January 09, 2026 Filed Jan 12, 2026 17:12 UTC |
Lyssikatos Joseph PCHIEF SCIENTIFIC OFFICER
|
SaleCommon Stock | 41,198 | $24.90 | $1,025,863.16 |
DisclosureSEC source: 0001967150-26-000001 · form4-01122026_100153.xml · nonDerivative · entry 3 Lyssikatos Joseph P · CIK 0001967150 · CHIEF SCIENTIFIC OFFICER 10b5-1 filing: Plan reported Ownership: Indirect · See footnote Disclosed balance after: 815,188 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 15, 2024. F5 · price: This transaction was executed in multiple trades at prices ranging from $24.90 to $24.92. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. F3 · ownership.nature: The shares are held by The Lyssikatos Revocable Trust 12/15/2011 for which the Reporting Person serves as trustee. Read SEC document |
| January 09, 2026 Filed Jan 12, 2026 22:11 UTC |
Heyman Richard A.Director
|
SaleCommon Stock | 4,285 | $25.00 | $107,125.43 |
DisclosureSEC source: 0001584759-26-000004 · form4-01122026_100112.xml · nonDerivative · entry 3 Heyman Richard A. · CIK 0001584759 · Director 10b5-1 filing: Plan reported Ownership: Indirect · See footnote Disclosed balance after: 25,107 F3 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 15, 2024 by the Reporting Person and by Richard A. Heyman and Anne E. Daigle Trust, UAD 01/01/1995, as amended November 1, 2016, for which the Reporting Person serves as trustee (the "Heyman Daigle Trust"). F6 · price: This transaction was executed in multiple trades at prices ranging from $25.00 to $25.05. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. F5 · ownership.nature: The shares are held of record by the Heyman Daigle Trust. Read SEC document |
| January 09, 2026 Filed Jan 13, 2026 22:54 UTC |
Patel AnishCHIEF OPERATING OFFICER
|
SaleCommon Stock | 243 | $28.50 | $6,925.50 |
DisclosureSEC source: 0001967163-26-000001 · form4-01132026_100110.xml · nonDerivative · entry 2 Patel Anish · CIK 0001967163 · CHIEF OPERATING OFFICER 10b5-1 filing: Plan reported Ownership: Indirect · See footnote Disclosed balance after: 215,011 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on September 30, 2024 by the Reporting Person and by The Patel / Dong Family Trust Dated August 24, 2017, for which the Reporting Person serves as trustee (the "Patel / Dong Family Trust"). F3 · ownership.nature: The shares are held by The Patel / Dong Family Trust. Read SEC document |
| January 09, 2026 Filed Jan 13, 2026 22:54 UTC |
Patel AnishCHIEF OPERATING OFFICER
|
SaleCommon Stock | 48,057 | $27.98 | $1,344,836.70 |
DisclosureSEC source: 0001967163-26-000001 · form4-01132026_100110.xml · nonDerivative · entry 1 Patel Anish · CIK 0001967163 · CHIEF OPERATING OFFICER 10b5-1 filing: Plan reported Ownership: Indirect · See footnote Disclosed balance after: 215,254 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on September 30, 2024 by the Reporting Person and by The Patel / Dong Family Trust Dated August 24, 2017, for which the Reporting Person serves as trustee (the "Patel / Dong Family Trust"). F2 · price: This transaction was executed in multiple trades at prices ranging from $27.50 to $28.38. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. F3 · ownership.nature: The shares are held by The Patel / Dong Family Trust. Read SEC document |
| January 08, 2026 Filed Jan 12, 2026 17:12 UTC |
Lyssikatos Joseph PCHIEF SCIENTIFIC OFFICER
|
SaleCommon Stock | 33,802 | $24.92 | $842,474.29 |
DisclosureSEC source: 0001967150-26-000001 · form4-01122026_100153.xml · nonDerivative · entry 2 Lyssikatos Joseph P · CIK 0001967150 · CHIEF SCIENTIFIC OFFICER 10b5-1 filing: Plan reported Ownership: Indirect · See footnote Disclosed balance after: 856,386 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 15, 2024. F4 · price: This transaction was executed in multiple trades at prices ranging from $24.90 to $25.065. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. F3 · ownership.nature: The shares are held by The Lyssikatos Revocable Trust 12/15/2011 for which the Reporting Person serves as trustee. Read SEC document |
| January 08, 2026 Filed Jan 12, 2026 17:12 UTC |
Lyssikatos Joseph PCHIEF SCIENTIFIC OFFICER
|
SaleCommon Stock | 7,500 | $20.13 | $150,961.50 |
DisclosureSEC source: 0001967150-26-000001 · form4-01122026_100153.xml · nonDerivative · entry 1 Lyssikatos Joseph P · CIK 0001967150 · CHIEF SCIENTIFIC OFFICER 10b5-1 filing: Plan reported Ownership: Indirect · See footnote Disclosed balance after: 890,188 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 15, 2024. F2 · price: This transaction was executed in multiple trades at prices ranging from $20.025 to $20.205. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. F3 · ownership.nature: The shares are held by The Lyssikatos Revocable Trust 12/15/2011 for which the Reporting Person serves as trustee. Read SEC document |
| January 08, 2026 Filed Jan 12, 2026 22:11 UTC |
Heyman Richard A.Director
|
SaleCommon Stock | 8,015 | $25.04 | $200,655.53 |
DisclosureSEC source: 0001584759-26-000004 · form4-01122026_100112.xml · nonDerivative · entry 2 Heyman Richard A. · CIK 0001584759 · Director 10b5-1 filing: Plan reported Ownership: Indirect · See footnote Disclosed balance after: 29,392 F3 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 15, 2024 by the Reporting Person and by Richard A. Heyman and Anne E. Daigle Trust, UAD 01/01/1995, as amended November 1, 2016, for which the Reporting Person serves as trustee (the "Heyman Daigle Trust"). F4 · price: This transaction was executed in multiple trades at prices ranging from $25.00 to $25.235. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. F5 · ownership.nature: The shares are held of record by the Heyman Daigle Trust. Read SEC document |
| January 08, 2026 Filed Jan 12, 2026 22:11 UTC |
Heyman Richard A.Director
|
SaleCommon Stock | 1,620 | $25.00 | $40,500.00 |
DisclosureSEC source: 0001584759-26-000004 · form4-01122026_100112.xml · nonDerivative · entry 1 Heyman Richard A. · CIK 0001584759 · Director 10b5-1 filing: Plan reported Ownership: Indirect · See footnote Disclosed balance after: 25,545 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 15, 2024 by RAHD Capital LLC, for which the Reporting Person serves as a managing member. F2 · ownership.nature: The shares are held of record by RAHD Capital LLC. Read SEC document |
| January 07, 2026 Filed Jan 9, 2026 23:10 UTC |
Garland J. ScottDirector
|
GrantStock Option (right to buy) · Derivative | 59,372 | $0.00 Strike: $15.47 | $0.00 |
DisclosureSEC source: 0001533228-26-000002 · form4-01092026_110126.xml · derivative · entry 1 Garland J. Scott · CIK 0001533228 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 59,372 Underlying: Common Stock · 59,372 shares Expires 2036-01-07 F1 · derivative.exercise_date: 1/36th of the shares subject to the option will vest on February 7, 2026 and each month thereafter, subject to the Reporting Person continuing as an outside director through each such date. Read SEC document |
| December 22, 2025 Filed Dec 23, 2025 23:47 UTC |
Hohl BenjaminCHIEF FINANCIAL OFFICER
|
Exercise / conversionStock Option (right to buy) · Derivative | 13,000 | $0.00 Strike: $2.48 | $0.00 |
DisclosureSEC source: 0001882764-25-000005 · form4-12232025_111212.xml · derivative · entry 2 Hohl Benjamin · CIK 0001882764 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 92,056 Underlying: Common Stock · 13,000 shares Expires 2031-08-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: All of the shares subject to this option are fully vested and exercisable as of the date hereof. Read SEC document |
| December 22, 2025 Filed Dec 23, 2025 23:47 UTC |
Hohl BenjaminCHIEF FINANCIAL OFFICER
|
Exercise / conversionCommon Stock | 13,000 | $2.48 | $32,240.00 |
DisclosureSEC source: 0001882764-25-000005 · form4-12232025_111212.xml · nonDerivative · entry 1 Hohl Benjamin · CIK 0001882764 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 19, 2025 Filed Dec 23, 2025 18:45 UTC |
Lyssikatos Joseph PCHIEF SCIENTIFIC OFFICER
|
SaleCommon Stock | 5,000 | $16.84 | $84,206.00 |
DisclosureSEC source: 0001967150-25-000008 · form4-12232025_111217.xml · nonDerivative · entry 1 Lyssikatos Joseph P · CIK 0001967150 · CHIEF SCIENTIFIC OFFICER 10b5-1 filing: Plan reported Ownership: Indirect · See footnote Disclosed balance after: 897,688 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 15, 2024. F2 · price: This transaction was executed in multiple trades at prices ranging from $16.605 to $17.115. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. F3 · ownership.nature: The shares are held by The Lyssikatos Revocable Trust 12/15/2011 for which the Reporting Person serves as trustee. Read SEC document |
| December 17, 2025 Filed Dec 19, 2025 22:58 UTC |
Kunkel Lori AnneDirector
|
Exercise / conversionStock Option (right to buy) · Derivative | 15,958 | $0.00 Strike: $1.12 | $0.00 |
DisclosureSEC source: 0001536368-25-000007 · form4-12192025_101209.xml · derivative · entry 3 Kunkel Lori Anne · CIK 0001536368 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,741 Underlying: Common Stock · 15,958 shares Expires 2030-06-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: All of the shares subject to this option are fully vested and exercisable as of the date hereof. Read SEC document |
| December 17, 2025 Filed Dec 19, 2025 22:58 UTC |
Kunkel Lori AnneDirector
|
Exercise / conversionCommon Stock | 15,958 | $1.12 | $17,872.96 |
DisclosureSEC source: 0001536368-25-000007 · form4-12192025_101209.xml · nonDerivative · entry 1 Kunkel Lori Anne · CIK 0001536368 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,712 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 11, 2025 Filed Dec 12, 2025 23:31 UTC |
Fair Richard A.Director · PRESIDENT AND CEO
|
GrantStock Option (right to buy) · Derivative | 875,000 | $0.00 Strike: $18.77 | $0.00 |
DisclosureSEC source: 0001695851-25-000004 · form4-12122025_111226.xml · derivative · entry 1 Fair Richard A. · CIK 0001695851 · Director · PRESIDENT AND CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 875,000 Underlying: Common Stock · 875,000 shares Expires 2035-12-11 F1 · derivative.exercise_date: 1/4th of the shares subject to the option will vest on December 11, 2026 and 1/48th of the shares subject to the option will vest each month thereafter, subject to the Reporting Person continuing as a service provider through each such date. Read SEC document |
| December 08, 2025 Filed Dec 10, 2025 22:13 UTC |
Patel AnishCHIEF OPERATING OFFICER
|
SaleCommon Stock | 1,705 | $21.78 | $37,133.88 |
DisclosureSEC source: 0001967163-25-000005 · form4-12102025_101217.xml · nonDerivative · entry 2 Patel Anish · CIK 0001967163 · CHIEF OPERATING OFFICER 10b5-1 filing: Plan reported Ownership: Indirect · See footnote Disclosed balance after: 263,311 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on September 30, 2024 by the Reporting Person and by The Patel / Dong Family Trust Dated August 24, 2017, for which the Reporting Person serves as trustee (the "Patel / Dong Family Trust"). F4 · price: This transaction was executed in multiple trades at prices ranging from $21.51 to $22.055. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. F3 · ownership.nature: The shares are held by The Patel / Dong Family Trust. Read SEC document |
| December 08, 2025 Filed Dec 10, 2025 22:13 UTC |
Patel AnishCHIEF OPERATING OFFICER
|
SaleCommon Stock | 4,958 | $20.76 | $102,938.99 |
DisclosureSEC source: 0001967163-25-000005 · form4-12102025_101217.xml · nonDerivative · entry 1 Patel Anish · CIK 0001967163 · CHIEF OPERATING OFFICER 10b5-1 filing: Plan reported Ownership: Indirect · See footnote Disclosed balance after: 265,016 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on September 30, 2024 by the Reporting Person and by The Patel / Dong Family Trust Dated August 24, 2017, for which the Reporting Person serves as trustee (the "Patel / Dong Family Trust"). F2 · price: This transaction was executed in multiple trades at prices ranging from $20.51 to $21.495. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. F3 · ownership.nature: The shares are held by The Patel / Dong Family Trust. Read SEC document |
| November 19, 2025 Filed Nov 21, 2025 17:28 UTC |
Lyssikatos Joseph PCHIEF SCIENTIFIC OFFICER
|
SaleCommon Stock | 492 | $23.09 | $11,360.77 |
DisclosureSEC source: 0001967150-25-000007 · form4-11212025_101158.xml · nonDerivative · entry 2 Lyssikatos Joseph P · CIK 0001967150 · CHIEF SCIENTIFIC OFFICER 10b5-1 filing: Plan reported Ownership: Indirect · See footnote Disclosed balance after: 902,688 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 15, 2024. F4 · price: This transaction was executed in multiple trades at prices ranging from $23.045 to $23.165. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. F3 · ownership.nature: The shares are held by The Lyssikatos Revocable Trust 12/15/2011 for which the Reporting Person serves as trustee. Read SEC document |
| November 19, 2025 Filed Nov 21, 2025 17:28 UTC |
Lyssikatos Joseph PCHIEF SCIENTIFIC OFFICER
|
SaleCommon Stock | 12,008 | $22.30 | $267,794.01 |
DisclosureSEC source: 0001967150-25-000007 · form4-11212025_101158.xml · nonDerivative · entry 1 Lyssikatos Joseph P · CIK 0001967150 · CHIEF SCIENTIFIC OFFICER 10b5-1 filing: Plan reported Ownership: Indirect · See footnote Disclosed balance after: 903,180 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 15, 2024. F2 · price: This transaction was executed in multiple trades at prices ranging from $22.035 to $23.01. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. F3 · ownership.nature: The shares are held by The Lyssikatos Revocable Trust 12/15/2011 for which the Reporting Person serves as trustee. Read SEC document |
| November 17, 2025 Filed Nov 19, 2025 18:45 UTC |
Kintz SamuelDirector · PRESIDENT AND CEO
|
SaleCommon Stock | 12,500 | $21.82 | $272,738.75 |
DisclosureSEC source: 0001967168-25-000008 · form4-11192025_111110.xml · nonDerivative · entry 1 Kintz Samuel · CIK 0001967168 · Director · PRESIDENT AND CEO 10b5-1 filing: Plan reported Ownership: Indirect · See footnote Disclosed balance after: 890,392 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 15, 2024. F2 · price: This transaction was executed in multiple trades at prices ranging from $21.37 to $22.3537. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. F3 · ownership.nature: The shares are held of record by The Kintz & Egan Trust Dated March 30, 2019 for which the reporting person serves as trustee. Read SEC document |
| November 07, 2025 Filed Nov 12, 2025 22:34 UTC |
Patel AnishCHIEF OPERATING OFFICER
|
SaleCommon Stock | 613 | $17.94 | $10,995.44 |
DisclosureSEC source: 0001967163-25-000004 · form4-11122025_101156.xml · nonDerivative · entry 2 Patel Anish · CIK 0001967163 · CHIEF OPERATING OFFICER 10b5-1 filing: Plan reported Ownership: Indirect · See footnote Disclosed balance after: 269,974 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on September 30, 2024 by the Reporting Person and by The Patel / Dong Family Trust Dated August 24, 2017, for which the Reporting Person serves as trustee (the "Patel / Dong Family Trust"). F4 · price: This transaction was executed in multiple trades at prices ranging from $17.835 to $18.265. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. F3 · ownership.nature: The shares are held by The Patel / Dong Family Trust. Read SEC document |
| November 07, 2025 Filed Nov 12, 2025 22:34 UTC |
Patel AnishCHIEF OPERATING OFFICER
|
SaleCommon Stock | 6,054 | $17.35 | $105,038.72 |
DisclosureSEC source: 0001967163-25-000004 · form4-11122025_101156.xml · nonDerivative · entry 1 Patel Anish · CIK 0001967163 · CHIEF OPERATING OFFICER 10b5-1 filing: Plan reported Ownership: Indirect · See footnote Disclosed balance after: 270,587 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on September 30, 2024 by the Reporting Person and by The Patel / Dong Family Trust Dated August 24, 2017, for which the Reporting Person serves as trustee (the "Patel / Dong Family Trust"). F2 · price: This transaction was executed in multiple trades at prices ranging from $16.825 to $17.8248. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. F3 · ownership.nature: The shares are held by The Patel / Dong Family Trust. Read SEC document |
| October 20, 2025 Filed Oct 22, 2025 19:20 UTC |
Lyssikatos Joseph PCHIEF SCIENTIFIC OFFICER
|
SaleCommon Stock | 12,500 | $22.08 | $276,025.00 |
DisclosureSEC source: 0001967150-25-000006 · form4-10222025_111054.xml · nonDerivative · entry 1 Lyssikatos Joseph P · CIK 0001967150 · CHIEF SCIENTIFIC OFFICER 10b5-1 filing: Plan reported Ownership: Indirect · See footnote Disclosed balance after: 915,188 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 15, 2024. F2 · price: This transaction was executed in multiple trades at prices ranging from $21.285 to $22.36. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. F3 · ownership.nature: The shares are held by The Lyssikatos Revocable Trust 12/15/2011 for which the Reporting Person serves as trustee. Read SEC document |
| October 17, 2025 Filed Oct 21, 2025 18:13 UTC |
Kintz SamuelDirector · PRESIDENT AND CEO
|
SaleCommon Stock | 12,500 | $21.33 | $266,653.75 |
DisclosureSEC source: 0001967168-25-000007 · form4-10212025_101038.xml · nonDerivative · entry 1 Kintz Samuel · CIK 0001967168 · Director · PRESIDENT AND CEO 10b5-1 filing: Plan reported Ownership: Indirect · See footnote Disclosed balance after: 902,892 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 15, 2024. F2 · price: This transaction was executed in multiple trades at prices ranging from $21.1303 to $21.88. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. F3 · ownership.nature: The shares are held of record by The Kintz & Egan Trust Dated March 30, 2019 for which the reporting person serves as trustee. Read SEC document |
| October 07, 2025 Filed Oct 9, 2025 21:21 UTC |
Patel AnishCHIEF OPERATING OFFICER
|
SaleCommon Stock | 6,667 | $20.10 | $133,992.70 |
DisclosureSEC source: 0001967163-25-000003 · form4-10092025_091058.xml · nonDerivative · entry 1 Patel Anish · CIK 0001967163 · CHIEF OPERATING OFFICER 10b5-1 filing: Plan reported Ownership: Indirect · See footnote Disclosed balance after: 276,641 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on September 30, 2024 by the Reporting Person and by The Patel / Dong Family Trust Dated August 24, 2017, for which the Reporting Person serves as trustee (the "Patel / Dong Family Trust"). F2 · price: This transaction was executed in multiple trades at prices ranging from $20.0001 to $20.22. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. F3 · ownership.nature: The shares are held by The Patel / Dong Family Trust. Read SEC document |
| September 29, 2025 Filed Oct 1, 2025 20:46 UTC |
Hohl BenjaminCHIEF FINANCIAL OFFICER
|
Exercise / conversionStock Option (right to buy) · Derivative | 3,250 | $0.00 Strike: $2.48 | $0.00 |
DisclosureSEC source: 0001882764-25-000004 · form4-10012025_081027.xml · derivative · entry 3 Hohl Benjamin · CIK 0001882764 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 105,056 Underlying: Common Stock · 3,250 shares Expires 2031-08-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023. F3 · derivative.exercise_date: All of the shares subject to this option are fully vested and exercisable as of the date hereof. Read SEC document |
| September 29, 2025 Filed Oct 1, 2025 20:46 UTC |
Hohl BenjaminCHIEF FINANCIAL OFFICER
|
SaleCommon Stock | 3,250 | $20.40 | $66,291.23 |
DisclosureSEC source: 0001882764-25-000004 · form4-10012025_081027.xml · nonDerivative · entry 2 Hohl Benjamin · CIK 0001882764 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 23,000 F1 · kind: The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023. F2 · price: This transaction was executed in multiple trades at prices ranging from $20.025 to $20.71. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. Read SEC document |
| September 29, 2025 Filed Oct 1, 2025 20:46 UTC |
Hohl BenjaminCHIEF FINANCIAL OFFICER
|
Exercise / conversionCommon Stock | 3,250 | $2.48 | $8,060.00 |
DisclosureSEC source: 0001882764-25-000004 · form4-10012025_081027.xml · nonDerivative · entry 1 Hohl Benjamin · CIK 0001882764 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 26,250 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023. Read SEC document |
| September 26, 2025 Filed Sep 30, 2025 17:53 UTC |
Lyssikatos Joseph PCHIEF SCIENTIFIC OFFICER
|
SaleCommon Stock | 4,000 | $20.25 | $81,005.20 |
DisclosureSEC source: 0001967150-25-000005 · form4-09302025_090907.xml · nonDerivative · entry 1 Lyssikatos Joseph P · CIK 0001967150 · CHIEF SCIENTIFIC OFFICER 10b5-1 filing: Plan reported Ownership: Indirect · See footnote Disclosed balance after: 927,688 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 15, 2024. F2 · price: This transaction was executed in multiple trades at prices ranging from $20.015 to $20.285. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. F3 · ownership.nature: The shares are held by The Lyssikatos Revocable Trust 12/15/2011 for which the Reporting Person serves as trustee. Read SEC document |
| September 26, 2025 Filed Sep 30, 2025 17:51 UTC |
Kintz SamuelDirector · PRESIDENT AND CEO
|
SaleCommon Stock | 3,700 | $20.06 | $74,227.55 |
DisclosureSEC source: 0001967168-25-000006 · form4-09302025_090944.xml · nonDerivative · entry 1 Kintz Samuel · CIK 0001967168 · Director · PRESIDENT AND CEO 10b5-1 filing: Plan reported Ownership: Indirect · See footnote Disclosed balance after: 915,392 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 15, 2024. F2 · price: This transaction was executed in multiple trades at prices ranging from $20.00 to $20.27. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. F3 · ownership.nature: The shares are held of record by The Kintz & Egan Trust Dated March 30, 2019 for which the reporting person serves as trustee. Read SEC document |
| September 23, 2025 Filed Sep 25, 2025 19:44 UTC |
Lyssikatos Joseph PCHIEF SCIENTIFIC OFFICER
|
SaleCommon Stock | 1,500 | $20.03 | $30,045.00 |
DisclosureSEC source: 0001967150-25-000004 · form4-09252025_110942.xml · nonDerivative · entry 1 Lyssikatos Joseph P · CIK 0001967150 · CHIEF SCIENTIFIC OFFICER 10b5-1 filing: Plan reported Ownership: Indirect · See footnote Disclosed balance after: 931,688 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 15, 2024. F2 · ownership.nature: The shares are held by The Lyssikatos Revocable Trust 12/15/2011 for which the Reporting Person serves as trustee. Read SEC document |
| September 23, 2025 Filed Sep 25, 2025 19:42 UTC |
Kintz SamuelDirector · PRESIDENT AND CEO
|
SaleCommon Stock | 2,800 | $20.03 | $56,084.00 |
DisclosureSEC source: 0001967168-25-000005 · form4-09252025_110953.xml · nonDerivative · entry 1 Kintz Samuel · CIK 0001967168 · Director · PRESIDENT AND CEO 10b5-1 filing: Plan reported Ownership: Indirect · See footnote Disclosed balance after: 919,092 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 15, 2024. F2 · ownership.nature: The shares are held of record by The Kintz & Egan Trust Dated March 30, 2019 for which the reporting person serves as trustee. Read SEC document |
| September 19, 2025 Filed Sep 19, 2025 19:12 UTC |
Kintz SamuelDirector · PRESIDENT AND CEO
|
SaleCommon Stock | 1,000 | $20.25 | $20,250.00 |
DisclosureSEC source: 0001967168-25-000004 · form4-09192025_110913.xml · nonDerivative · entry 2 Kintz Samuel · CIK 0001967168 · Director · PRESIDENT AND CEO 10b5-1 filing: Plan reported Ownership: Indirect · See footnote Disclosed balance after: 921,892 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 15, 2024. F4 · price: This transaction was executed in multiple trades at prices ranging from $20.015 to $20.035. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. F3 · ownership.nature: The shares are held of record by The Kintz & Egan Trust Dated March 30, 2019 for which the reporting person serves as trustee. Read SEC document |
| September 19, 2025 Filed Sep 23, 2025 17:14 UTC |
Lyssikatos Joseph PCHIEF SCIENTIFIC OFFICER
|
SaleCommon Stock | 2,130 | $20.02 | $42,634.08 |
DisclosureSEC source: 0001967150-25-000003 · form4-09232025_090918.xml · nonDerivative · entry 2 Lyssikatos Joseph P · CIK 0001967150 · CHIEF SCIENTIFIC OFFICER 10b5-1 filing: Plan reported Ownership: Indirect · See footnote Disclosed balance after: 933,188 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 15, 2024. F4 · price: This transaction was executed in multiple trades at prices ranging from $19.95 to $20.0469. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. F3 · ownership.nature: The shares are held by The Lyssikatos Revocable Trust 12/15/2011 for which the Reporting Person serves as trustee. Read SEC document |
| September 19, 2025 Filed Sep 23, 2025 17:14 UTC |
Lyssikatos Joseph PCHIEF SCIENTIFIC OFFICER
|
SaleCommon Stock | 4,870 | $19.11 | $93,063.27 |
DisclosureSEC source: 0001967150-25-000003 · form4-09232025_090918.xml · nonDerivative · entry 1 Lyssikatos Joseph P · CIK 0001967150 · CHIEF SCIENTIFIC OFFICER 10b5-1 filing: Plan reported Ownership: Indirect · See footnote Disclosed balance after: 935,318 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 15, 2024. F2 · price: This transaction was executed in multiple trades at prices ranging from $18.94 to $19.89. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. F3 · ownership.nature: The shares are held by The Lyssikatos Revocable Trust 12/15/2011 for which the Reporting Person serves as trustee. Read SEC document |
| September 17, 2025 Filed Sep 19, 2025 19:12 UTC |
Kintz SamuelDirector · PRESIDENT AND CEO
|
SaleCommon Stock | 5,000 | $19.09 | $95,473.00 |
DisclosureSEC source: 0001967168-25-000004 · form4-09192025_110913.xml · nonDerivative · entry 1 Kintz Samuel · CIK 0001967168 · Director · PRESIDENT AND CEO 10b5-1 filing: Plan reported Ownership: Indirect · See footnote Disclosed balance after: 922,892 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 15, 2024. F2 · price: This transaction was executed in multiple trades at prices ranging from $18.56 to $19.51. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. F3 · ownership.nature: The shares are held of record by The Kintz & Egan Trust Dated March 30, 2019 for which the reporting person serves as trustee. Read SEC document |
| September 08, 2025 Filed Sep 11, 2025 00:12 UTC |
Patel AnishCHIEF OPERATING OFFICER
|
SaleCommon Stock | 6,667 | $20.24 | $134,957.41 |
DisclosureSEC source: 0001415889-25-024196 · form4-09112025_120931.xml · nonDerivative · entry 1 Patel Anish · CIK 0001967163 · CHIEF OPERATING OFFICER 10b5-1 filing: Plan reported Ownership: Indirect · See footnote Disclosed balance after: 283,308 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on September 30, 2024 by the Reporting Person and by The Patel / Dong Family Trust Dated August 24, 2017, for which the Reporting Person serves as trustee (the "Patel / Dong Family Trust"). F2 · price: This transaction was executed in multiple trades at prices ranging from $19.915 to $20.64. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. F3 · ownership.nature: The shares are held by The Patel / Dong Family Trust. Read SEC document |
| August 27, 2025 Filed Aug 29, 2025 21:03 UTC |
Hohl BenjaminCHIEF FINANCIAL OFFICER
|
Exercise / conversionStock Option (right to buy) · Derivative | 3,250 | $0.00 Strike: $2.48 | $0.00 |
DisclosureSEC source: 0001415889-25-023310 · form4-08292025_090813.xml · derivative · entry 3 Hohl Benjamin · CIK 0001882764 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 108,306 Underlying: Common Stock · 3,250 shares Expires 2031-08-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023. F3 · derivative.exercise_date: All of the shares subject to this option are fully vested and exercisable as of the date hereof. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.